Accepted answer
Week 5 is day 35: on a four-week ladder that is week 1 of dose step 2, and — at the seven-day half-life this class runs on — 5 half-lives in. Steady state is about five half-lives, so day 35 is where the concentration stops climbing on its own. Day 35 is exactly that point. That distinction is most of the question: at week 1 of a step, an effect that is still accumulating is indistinguishable from one that is not resolving unless you know which side of day 35 you are on. Fatigue at any week has at least three candidate sources — the energy deficit, the fall in micronutrient intake that rides along with it, and the agent itself — and only the first two are cheaply measurable. Dose decisions are made under supervision, and nothing here is medical advice.
Answer first: fatigue in this context is usually an energy-intake problem before it is a drug effect, and the arithmetic is the first place to look.
A deficit beyond about a thousand kilocalories a day reliably produces fatigue, reduced training performance and reduced spontaneous movement. With appetite suppressed, deficits of that size arrive by accident rather than by plan.
Three days of honest weighed intake usually settles this. Estimated intake in this situation is systematically wrong and usually wrong in the direction that hides the problem.
Ferritin as an acute-phase reactant is a recognised limitation and is why it is interpreted alongside an inflammatory marker.
Attributing a symptom with a wide differential to the most recent change is a common and expensive error.
Weigh three days of intake honestly. That answers this most of the time.